Custom Health Holdings (TSX:CHLT) Research & Development: C$ Mil (TTM As of Jun. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

TSX:CHLT Custom Health Holdings Inc TSX:CHLT
8 GF Score
Price C$7.25
! 2 Warning Signs
View Full Analysis

What is Custom Health Holdings Research & Development?

Custom Health Holdings TSX:CHLT +0.69% 8 Research & Development is C$ Mil as of Jun. 2026. GuruFocus rates TSX:CHLT with a GF Score™ of 8/100. The stock has 2 warning signs investors should review.

Research & Development is the aggregate amount of research and development expenses during the year. Custom Health Holdings's Research & Development for the three months ended in Jun. 2026 was C$0.00 Mil. Custom Health Holdings does not have enough years/quarters to calculate the Research & Development for the trailing twelve months (TTM) ended in Jun. 2026.

Custom Health Holdings  (TSX:CHLT) Research & Development Explanation

If competitive advantage is created by a patent or tech advantage, at some point it will disappear.

High R&D usually dictates high SG&A which threatens the competitive advantage.

Custom Health Holdings Research & Development Related Terms

Custom Health Holdings Research & Development Historical Data

* Premium members only.

The historical data trend for Custom Health Holdings's Research & Development can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Custom Health Holdings Research & Development Chart

Custom Health Holdings Annual Data
Trend Mar25
Research & Development
0.00

Custom Health Holdings Quarterly Data
Mar25 Mar26 Jun26
Research & Development 0.00 0.00 0.00
TSX:CHLT
8GF Score
Custom Health Holdings Inc TSX:CHLT
Research & Development is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Custom Health Holdings Research & Development Calculation

This is the expense the company spent on research and development.

Frequently Asked Questions Learn more about Research & Development →
What does a Research & Development of C$ Mil mean?
Custom Health Holdings (TSX:CHLT) has a Research & Development of C$ Mil as of Jun. 2026. Research and development expense is the total cost for research and development activities. View historical data on Custom Health Holdings and its competitors.
Is Custom Health Holdings' Research & Development too high?
Custom Health Holdings' current Research & Development is C$ Mil. Overall, Custom Health Holdings has a GF Score™ of 8/100, reflecting its overall financial health beyond just this single metric.
How does Custom Health Holdings' Research & Development compare to VEEV and BTSG?
Custom Health Holdings' Research & Development of C$ Mil can be compared against companies in the Healthcare Providers & Services industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Research & Development for a Healthcare Providers & Services company?
A good Research & Development depends on the Healthcare Providers & Services industry context. However, Research & Development should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Research & Development mean?
A high Research & Development can signal that a stock is expensive relative to its fundamentals. Research and development expense is the total cost for research and development activities. View historical data on Custom Health Holdings and its competitors. Custom Health Holdings's current Research & Development is C$ Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Custom Health Holdings stock overvalued right now?
Custom Health Holdings (TSX:CHLT) has a current Research & Development of C$ Mil. The current Research & Development is C$ Mil. Custom Health Holdings' overall GF Score™ is 8/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Research & Development calculated?
Research & Development is calculated from a company's financial statements. For Custom Health Holdings (TSX:CHLT), the current Research & Development is C$ Mil as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Custom Health Holdings Business Description

Address 1631 Dickson Avenue, Suite 900, Kelowna, BC, CAN, V1Y 0B5
Custom Health Holdings Inc connects pharmacy, in-home technology, and pharmacist-led clinical oversight to create earlier visibility into how medications are used and experienced at home. Its solutions are Provider, Health Plans & Government, and Patients & Caregivers.
8GF Score

Get the complete analysis for TSX:CHLT

Research & Development is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

C$7.25
Price